FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1963676875> ?p ?o ?g. }

• W1963676875 endingPage "733" @default.
• W1963676875 startingPage "726" @default.
• W1963676875 abstract "It is estimated that 10.3 million people aged 15–24 are living with HIV infection/AIDS worldwide, with 7000 new infections occurring each day. Many of these infections occur during the adolescent years. These rates of infection make adolescents an important target for research in primary prevention. Currently, preparations are under way by the National Institutes of Health–supported HIV networks—the Adolescent Trials Network, the Pediatric AIDS Clinical Trials Group, and the HIV Vaccines Trials Network—for phase 1/2 HIV vaccine trials involving adolescents in the United States. Identifying the challenges to conducting HIV vaccine trials with this population is a crucial component of these preparations. Challenges to HIV vaccine trials with adolescents were identified by reviewing previous vaccine research for adolescents and HIV infection in adolescents and speaking with experts in HIV/AIDS and adolescent medicine. Adolescents (typically those younger than 18 years of age) are minors and fall under ethical and regulatory safeguards for their participation in clinical research including parental permission. Adolescents may not appropriately perceive personal risk, posing challenges for informed consent as well as prevention counseling during a trial. Safety and immunogenicity studies of adolescents are likely to be required by the US Food and Drug Administration before vaccine approval for this population. Early identification and subsequent follow-up of high-risk adolescents are problematic. Vaccine-induced seropositivity may present potential barriers to military service, employment, marriage, and acquiring health insurance. The age at optimal immunization, particularly for girls in some countries, may be during preadolescence. The successful completion of HIV vaccine trials with adolescents must address these challenges both in the United States and internationally. This report addresses relevant background information, identifies the issues surrounding HIV vaccine trials with adolescents, discusses what progress has been made, and addresses plans and implications for the implementation of these trials." @default.
• W1963676875 created "2016-06-24" @default.
• W1963676875 creator A5002707102 @default.
• W1963676875 creator A5011671349 @default.
• W1963676875 creator A5017734649 @default.
• W1963676875 creator A5043233857 @default.
• W1963676875 date "2004-06-01" @default.
• W1963676875 modified "2023-09-25" @default.
• W1963676875 title "Challenges to Conducting HIV Preventative Vaccine Trials With Adolescents" @default.
• W1963676875 cites W1966157359 @default.
• W1963676875 cites W1980110655 @default.
• W1963676875 cites W1996953352 @default.
• W1963676875 cites W1998481624 @default.
• W1963676875 cites W2004466868 @default.
• W1963676875 cites W2015058613 @default.
• W1963676875 cites W2017026570 @default.
• W1963676875 cites W2024133326 @default.
• W1963676875 cites W2027215192 @default.
• W1963676875 cites W2049980106 @default.
• W1963676875 cites W2057684367 @default.
• W1963676875 cites W2086229583 @default.
• W1963676875 cites W2097737020 @default.
• W1963676875 cites W2134529302 @default.
• W1963676875 cites W2139838125 @default.
• W1963676875 cites W2142862769 @default.
• W1963676875 cites W2143726041 @default.
• W1963676875 cites W2342332506 @default.
• W1963676875 cites W2399387692 @default.
• W1963676875 cites W2605607048 @default.
• W1963676875 cites W4211103925 @default.
• W1963676875 doi "https://doi.org/10.1097/00126334-200406010-00010" @default.
• W1963676875 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15167292" @default.
• W1963676875 hasPublicationYear "2004" @default.
• W1963676875 type Work @default.
• W1963676875 sameAs 1963676875 @default.
• W1963676875 citedByCount "46" @default.
• W1963676875 countsByYear W19636768752012 @default.
• W1963676875 countsByYear W19636768752013 @default.
• W1963676875 countsByYear W19636768752014 @default.
• W1963676875 countsByYear W19636768752015 @default.
• W1963676875 countsByYear W19636768752018 @default.
• W1963676875 countsByYear W19636768752019 @default.
• W1963676875 countsByYear W19636768752020 @default.
• W1963676875 countsByYear W19636768752021 @default.
• W1963676875 crossrefType "journal-article" @default.
• W1963676875 hasAuthorship W1963676875A5002707102 @default.
• W1963676875 hasAuthorship W1963676875A5011671349 @default.
• W1963676875 hasAuthorship W1963676875A5017734649 @default.
• W1963676875 hasAuthorship W1963676875A5043233857 @default.
• W1963676875 hasBestOaLocation W19636768751 @default.
• W1963676875 hasConcept C126322002 @default.
• W1963676875 hasConcept C138496976 @default.
• W1963676875 hasConcept C142724271 @default.
• W1963676875 hasConcept C15744967 @default.
• W1963676875 hasConcept C159110408 @default.
• W1963676875 hasConcept C187212893 @default.
• W1963676875 hasConcept C193739211 @default.
• W1963676875 hasConcept C204787440 @default.
• W1963676875 hasConcept C2778063736 @default.
• W1963676875 hasConcept C2778190748 @default.
• W1963676875 hasConcept C2779171700 @default.
• W1963676875 hasConcept C2780195530 @default.
• W1963676875 hasConcept C2781247642 @default.
• W1963676875 hasConcept C2908647359 @default.
• W1963676875 hasConcept C3013748606 @default.
• W1963676875 hasConcept C512399662 @default.
• W1963676875 hasConcept C535046627 @default.
• W1963676875 hasConcept C68122502 @default.
• W1963676875 hasConcept C71924100 @default.
• W1963676875 hasConcept C99454951 @default.
• W1963676875 hasConceptScore W1963676875C126322002 @default.
• W1963676875 hasConceptScore W1963676875C138496976 @default.
• W1963676875 hasConceptScore W1963676875C142724271 @default.
• W1963676875 hasConceptScore W1963676875C15744967 @default.
• W1963676875 hasConceptScore W1963676875C159110408 @default.
• W1963676875 hasConceptScore W1963676875C187212893 @default.
• W1963676875 hasConceptScore W1963676875C193739211 @default.
• W1963676875 hasConceptScore W1963676875C204787440 @default.
• W1963676875 hasConceptScore W1963676875C2778063736 @default.
• W1963676875 hasConceptScore W1963676875C2778190748 @default.
• W1963676875 hasConceptScore W1963676875C2779171700 @default.
• W1963676875 hasConceptScore W1963676875C2780195530 @default.
• W1963676875 hasConceptScore W1963676875C2781247642 @default.
• W1963676875 hasConceptScore W1963676875C2908647359 @default.
• W1963676875 hasConceptScore W1963676875C3013748606 @default.
• W1963676875 hasConceptScore W1963676875C512399662 @default.
• W1963676875 hasConceptScore W1963676875C535046627 @default.
• W1963676875 hasConceptScore W1963676875C68122502 @default.
• W1963676875 hasConceptScore W1963676875C71924100 @default.
• W1963676875 hasConceptScore W1963676875C99454951 @default.
• W1963676875 hasIssue "2" @default.
• W1963676875 hasLocation W19636768751 @default.
• W1963676875 hasLocation W19636768752 @default.
• W1963676875 hasLocation W19636768753 @default.
• W1963676875 hasOpenAccess W1963676875 @default.
• W1963676875 hasPrimaryLocation W19636768751 @default.
• W1963676875 hasRelatedWork W183890156 @default.
• W1963676875 hasRelatedWork W1963676875 @default.

• next